And thats going to come through transparency, and transparency laws that are passed for us to be able to collect that information, and be able to then come up with policy solutions that actually address the data points that we see are not helping out first and foremost, the patients
Experimental investigations evaluating growth hormone secretagogues report that receptor specificity significantly influences endocrine selectivity
It is explicitly not framed as the right answer for everyone
Endogenous GIP is secreted most potently in response to high lipid meals [16], while GIP infusion enhances adipose tissue blood flow in lean patients [17] and lipid deposition (e.g., reduced plasma non-essential fatty acids (NEFA), increased adipose triglycerides (TG)) in patients with obesity and type 2 diabetes (T2D) [18]
This includes an investigational, potential first-in-class triple GLP-1, GIP, NPY2 receptor agonist peptide (BI 3034701), which will be entering Phase II in the middle of 2026, as well as additional experimental approaches including oral treatment options
Bottom line: While taking metformin and Wegovy together is generally safe and often beneficial, a personalized medical plan is required to ensure you lose weight comfortably and effectively